Metered Dose Inhaler Devices Include Clinical Trials, Pipeline Stage and Product
Posted by Deeksha on June 6th, 2019
The market for Metered Dose Inhaler Devices is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Metered Dose Inhaler Devices” - Medical Devices Pipeline Assessment, 2019 which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore, an anticipated growth at a double-digit CAGR for the Metered Dose Inhaler Devices sector is highlighted in the report which indicates a prosperous future.
Request Sample Copy of the Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2374713
Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Metered Dose Inhaler Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Metered Dose Inhaler Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Scope
- Extensive coverage of the Metered Dose Inhaler Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Metered Dose Inhaler Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Metered Dose Inhaler Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date.
Browse Full Report with TOC@ https://www.marketresearchhub.com/report/metered-dose-inhaler-devices-medical-devices-pipeline-assessment-2019-report.html
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Metered Dose Inhaler Devices Overview
3 Products under Development
3.1 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
3.2 Metered Dose Inhaler Devices - Pipeline Products by Territory
3.3 Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
3.4 Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
3.5 Metered Dose Inhaler Devices - Ongoing Clinical Trials
4 Metered Dose Inhaler Devices - Pipeline Products under Development by Companies
4.1 Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
4.2 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
5 Metered Dose Inhaler Devices Companies and Product Overview
5.1 Adamis Pharmaceuticals Corp Company Overview
5.2 Aerophase Inc Company Overview
5.3 AstraZeneca Plc Company Overview
5.4 Circassia Pharmaceuticals Plc Company Overview
5.5 Globe Medical Tech Inc (Inactive) Company Overview
5.6 Lab Automate Technologies Inc Company Overview
5.7 Lupin Pharmaceuticals Inc Company Overview
5.8 Medicom Innovation Partner a/s Company Overview
5.9 Min USA LLC Company Overview
5.10 Pearl Therapeutics Inc Company Overview
5.11 Reciprocal Labs Corp Company Overview
5.12 Rensselaer Polytechnic Institute Company Overview
5.13 Vectura Group Plc Company Overview
5.14 Verona Pharma Plc Company Overview
6 Metered Dose Inhaler Devices- Recent Developments
6.1 Apr 30, 2019: Merck announces first-quarter 2019 financial results
6.2 Apr 24, 2019: Novartis starts 2019 with strong sales and double digit core operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded
6.3 Apr 17, 2019: Financial year 2018: Boehringer Ingelheim grows and invests
6.4 Apr 12, 2019: Cipla launches Niveoli, Indias first extra-fine ICS-LABA combination HFA inhaler
6.5 Apr 09, 2019: Novartis continues transformation into a leading medicines company with completion of the Alcon spin-off
6.6 Apr 02, 2019: Alcon announces Timothy Stonesifer as Chief Financial Officer
6.7 Apr 02, 2019: 3M Drug Delivery Systems relocates UK R&D to new, state-of-the-art facility
6.8 Apr 01, 2019: Vectura Group names Kevin Matthews to its board of directors
6.9 Mar 26, 2019: Vectura Group 2018 preliminary results
6.10 Mar 22, 2019: Sosei Heptares announces that Ultibro Breezhaler and Seebri Breezhaler launched in China for the treatment of COPD
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
Continued………..#@
